TRENDS AND MARKET OUTLOOK REPORTS

• Sterile Injectable Drug Product Manufacturing Market Outlook: 2023-2028

  This report explores which delivery formats drug innovators are using in their pipelines and portfolios, how likely innovators are to outsource manufacturing based on delivery device, and how these proportions will shift over the next five years.

• Cell & Gene Therapies Manufacturing Market Outlook (2nd Ed.)

  Current market dynamics and outlook of the cell & gene therapies contract manufacturing space and predictions on what the marketplace will look like in 2028. Key stats include the volume of cell therapies/gene therapies in sponsors’ pipelines, corresponding manufacturing activities that will be outsourced, average outsourcing expenditure on cell and/or gene therapies, and number of CDMOs required to complete the work.

• Emerging Biopharma Perspective On Highly Potent API Manufacturing Market

  An overview of the current market dynamics for high containment manufacturing from the perspective of HPAPI manufacturing decision-makers at sponsor organizations at small and midsize biopharmaceutical companies and their predictions on what the market will look like in five years.

• Highly Potent API Market Outlook

  This report provides an overview of the current market dynamics for high containment manufacturing as well as an outlook on what some HPAPI manufacturing decision-makers at sponsor organizations predict the marketplace will look like five years from now.

• Oral Dosage Forms Market Overview and Outlook (4th Edition)

  This market research report provides an overview of the current market dynamics in the oral dose contract manufacturing space as well as an outlook of what our survey respondents—all oral dose outsourcing decision-makers at sponsor organizations—predict the marketplace will look like in 2024. Key statistics include oral dose project volume, percentage outsourced, and the average number of CMOs used to...

• Clinical Manufacturing Market Dynamics and Service Provider Benchmarking

  This report provides an overview of the current market dynamics in the clinical manufacturing space as well as an outlook of what our survey respondents predict the marketplace will look like in 2022.

• Bioprocessing Market Trends and Outsourcing Dynamics: 2020-2025 (3rd Edition)

  This market research report affords readers the opportunity to gain insight into the bioprocessing market and where it’s heading. This report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what our survey respondents predict the marketplace will look like in five years.

• Pharmaceutical Excipient Market Overview and Outlook

  This market research report offers readers the opportunity to gain insight into the biopharmaceutical excipient market and where it’s heading. Remaining aware of market dynamics and expected changes will enable readers to better make key decisions regarding excipient use and to help identify where competitive advantages may be gained.

• Development vs. Commercial Outsourced Manufacturing Practices: Small Molecule

  This report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.

• Development vs Commercial Outsourced Manufacturing Practices: Biologics

  This market research report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.

CONTRACT MANUFACTURER QUALITY BENCHMARKING

• Gene Therapy CDMO Benchmarking

  This research provides gene therapy companies and contract manufacturers with the latest insights, outsourcing trends, and best practices reported within the specific domain, as well as benchmarks for assessing service quality among the 14 CDMOs featured in the report.

• Biologic API CDMO Benchmarking (8th Ed.)

  This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CDMO service quality.

• Small Molecule API CDMO Benchmarking (8th Ed.)

  This report will help biopharma companies make more informed CDMO decisions, and will help CDMOs optimize operational and marketing strategies.

• Biologic Drug Product CDMO Benchmarking (6th Ed.)

  This report offers insight into how individual CDMOs performed through analysis of 449 captured service encounters among 134 respondents who are involved in biologic drug product manufacturing.

• Small Molecule Drug Product CDMO Benchmarking (6th Ed.)

  This report contains data from 411 service encounters from 127 respondents who have been involved in outsourcing small molecule drug product projects in the past 18 months.

• Biologic API CDMO Benchmarking For New & Emerging Pharma

  This report is based on responses from 45 people involved in outsourced large molecule API projects over the last 18 months. It will help new/emerging pharma companies make informed CDMO selections, and help CDMOs better understand how they are perceived.

DEPARTMENT MODELS AND STRUCTURES

• The CMC Function At Emerging Pharma

  This report provides an in-depth exploration of the role and function of Chemistry, Manufacturing, and Controls (CMC) throughout the stages of product development, spanning preclinical, clinical, and commercialization phases. A specific emphasis is placed on the configuration of the CMC function within virtual and small biopharmaceutical companies.

• CDMO Outsourcing Models (4th Ed.)

  This market research report explores how sponsor organizations use contract manufacturers to streamline costs, better manage capacity, access scientific expertise, improve efficiencies and decrease time to market.

• Benchmarking the Pharma Industry’s Market Research Function

  ISR conducted five in-depth interviews and 31 online surveys with experienced market researchers in the biopharmaceutical space to gain a better grasp on the market research function. Research subjects shared their insights on the types of research performed, how their market research function is structured, and outsourcing behavior.

• The CMC Function: Best Practices and Optimization

  ISR interviewed 15 CMC professionals at 14 Top 50 pharmaceutical and biotechnology companies, as well as one company outside the Top 50 to better understand the Chemistry Manufacturing and Controls function throughout the preclinical, clinical, and commercialization phases of the product development process.

• Benchmarking The Pharma Industry’s Medical Science Liaison (MSL) Function

  This market research report has been designed to be used as a benchmarking tool for companies to compare their Medical Science Liaison functions to those of other pharmaceutical and biotech organizations. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within...